1[1]Bercovich E.Anew target for urology:Aging and renal function[J].Urologia Internationalis,2002;69(2):91-94.
2[2]Abrass CK.Glomerulonephritis in the elderly[J].Am J Nephrol,1985;5(6):409-418.
3[3]Jungers P,Chauveau P,Descamps-Latscha B,et al.Age and gender-related incidence of chronis renal failure in a French urban area:A prospective epidemiologic study[J].Nephrol Dial Transplant,1996;11(8):1542-1546.
4[4]Jones C,McQuillan G,Kusek J,et al.Serum creatinine levels in the US population:Thid National Health and Nutrition Examination Survey[J].Am J Kidney Dis,1998;32(6):992-999.
5[5]Locatello F,Marcelli D,Conte F,et al.For the /registro Lombardo Dialisi e Trapianto.Cardiovascular disease in chronic renal failure:The challenge continues[J].Nephrol Dial Transplant,2000;15(Suppl 5):69-80.
6[6]Davison AM.Renal disease in the elderly[J].Nephron,1998;80(1):6-16.
7[7]Muhlberg W,Plat D.Age-dependent changes of the kidneys:Phar-macological implications[J].Gerontology,1999;45(5):243-253.
6Terpstra WF,May JF.Microalbuminuria is related to marked end organ damage in previously untreted,elderly hypertension[J].Blood Pressure,2002,11(2):84-90.
7Heart Outcomes Prevention Evaluation Study Investigators.Effects of pefindopril on cardiovascular and icrovascular otcomes in people with diabetes mellitus.Results of the HOPE Study and MICRO-HOPE study[J].Lancet,2000,355(9200):253-259.
8Parring HH,Hendrik Lehnert DM,Broehner Mortensen J,et al.The effect of irbesartan on the development of diatetic nephropathy in patients with type 2 diabetes and microal buminuria[J].N Eng J Med,2001,345(12):870-878.
9Praga M,Gutierrez E,Gonzalez E,et al.Treatment of IgA nephropathy with ACE inhibitors:a randomized and controlled trial[J].J Am Soc Nephrol,2003,14(6):1578-1583.
